查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1753971

2025 年至 2033 年冠狀動脈支架市場報告（按類型、生物材料、交付方式、最終用戶和地區）

Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球冠狀動脈支架市場規模達117億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到189億美元，2025-2033年期間的複合年成長率（CAGR）為5.18%。該市場正在經歷顯著成長，主要原因是心血管疾病患病率上升、支架技術進步以及老齡人口成長。新興市場和技術創新（例如生物可吸收支架）進一步推動了全球市場的成長。

冠狀動脈支架是一種小型自膨脹管狀金屬裝置，在球囊血管成形術後置入狹窄的冠狀動脈內，以保持動脈通暢。這些支架表面塗有藥物，藥物會緩慢釋放，防止動脈壁斑塊堆積和再次狹窄。它們還能緩解心臟病症狀，例如胸痛和呼吸急促，並維持血液和氧氣正常流向心臟。由於冠狀動脈支架具有微創（MI）特性且恢復時間較短，因此在世界各地，它正逐漸取代冠狀動脈繞道手術。

冠狀動脈支架市場趨勢：

藥物洗脫支架（DES）日益受到青睞

藥物洗脫支架 (DES) 因其在減少再狹窄（即支架置入後動脈再次變窄）方面的有效性，正成為比裸金屬支架 (BMS) 更受歡迎的選擇。這些支架上塗有緩慢釋放的藥物，可防止動脈內形成瘢痕組織，顯著降低阻塞風險。例如，2024 年 5 月，雅培在印度推出了 XIENCE Sierra 依維莫司洗脫冠狀動脈支架系統，該系統採用增強型支架設計，配備新的輸送系統和獨特的尺寸，有助於治療複雜病例。該支架採用特殊塗層，可減少動脈再次阻塞，並已證明其在治療棘手病變和複雜病症方面有效。與此一致，臨床研究表明，與 BMS 相比，DES 可減少重複手術的需求，從而改善長期療效。根據冠狀動脈支架市場分析，由於藥物洗脫支架（DES）在減少再狹窄和長期併發症方面的卓越性能，其採用率高於裸金屬支架，因此市場將實現顯著成長。

技術進步

冠狀動脈支架的技術進步包括生物可吸收支架的開發，該支架在完成工作後即可溶解，從而消除了長期植入的需求，並降低了晚期支架內血栓形成等風險。例如，2024年7月，微創醫療科學有限公司的Firesorb(R)生物可吸收心臟支架獲得中國國家藥品監督管理局的批准。此支架在臨床研究中表現出色，標靶病變失敗率和血栓形成率較低。藥物塗層球囊是另一項創新技術，可將藥物直接輸送至動脈，不留下永久性裝置，通常適用於複雜病變或再狹窄風險較高的患者。這些技術旨在透過減少長期併發症、促進血管癒合以及在冠狀動脈介入治療中提供更個人化的治療方案來改善患者預後。

老年人口成長及心血管疾病發生率上升

隨著全球老年人口的不斷成長，心血管疾病，特別是冠狀動脈疾病的發生率也在上升。根據世界衛生組織 (WHO) 發布的報告，到 2030 年，每 6 個人中就有 1 個人年齡超過 60 歲，全球老齡人口將達到 14 億。到 2050 年，這一數字將加倍，達到 21 億，其中 4.26 億人年齡在 80 歲或以上。由於膽固醇積聚等與年齡相關的因素，動脈會變硬變窄，因此越來越需要接受冠狀動脈介入治療。老年人群更容易患心臟病，這推動了對冠狀動脈支架的需求，以恢復血流並預防心臟病發作等併發症。支架技術的進步，加上老年患者對安全、有效的治療的需求，大大促進了冠狀動脈支架市場的成長。全球預期壽命的延長和醫療服務可近性的改善進一步推動了這項需求。

本報告回答的關鍵問題

  • 2024年全球冠狀動脈支架市場規模？ 2025-2033年全球冠狀動脈支架市場的預期成長率是多少？
  • 推動全球冠狀動脈支架市場的關鍵因素有哪些？
  • COVID-19 對全球冠狀動脈支架市場有何影響？
  • 全球冠狀動脈支架市場依類型分為哪些類型？
  • 根據生物材料，全球冠狀動脈支架市場如何分佈？
  • 根據交付方式，全球冠狀動脈支架市場如何分佈？
  • 根據最終用戶，全球冠狀動脈支架市場的分佈如何？
  • 全球冠狀動脈支架市場的主要區域有哪些？
  • 全球冠狀動脈支架市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球冠狀動脈支架市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 藥物洗脫支架
  • 裸金屬冠狀動脈支架
  • 生物可吸收支架

第7章：市場區隔：依生物材料

  • 金屬生物材料
  • 聚合物生物材料
  • 天然生物材料

第8章：市場區隔：依交付方式

  • 球囊擴張支架
  • 自膨式支架

第9章：市場區隔：依最終用戶

  • 醫院
  • 門診手術中心
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Elixir Medical Corporation
    • Lepu Medical Technology (Beijing) Co. Ltd.
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • Translumina GmbH
Product Code: SR112025A6083

The global coronary stents market size reached USD 11.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.18% during 2025-2033. The market is experiencing significant growth mainly driven by the rising prevalence of cardiovascular diseases, advancements in stent technology and a growing elderly population. Emerging markets and technological innovations, such as bioresorbable stents, further propels market growth across the globe.

Coronary stents are small, self-expanding tubular metallic devices introduced inside narrow coronary arteries to keep them open after a balloon angioplasty procedure. These stents are coated with a medication, which is slowly released to prevent the walls of arteries from plaque buildup and re-narrowing. They also alleviate heart disease symptoms, such as chest pain and shortness of breath, and allow normal flow of blood and oxygen to the heart. As they are minimally invasive (MI) and require shorter recovery time, coronary stents are gaining traction over coronary artery bypass surgeries around the world.

Coronary Stents Market Trends:

Rising Preference for Drug-Eluting Stents (DES)

Drug-eluting stents (DES) are becoming the preferred option over bare-metal stents (BMS) due to their effectiveness in reducing restenosis which is the re-narrowing of arteries after stenting. These stents are coated with medication that is slowly released to prevent the formation of scar tissue within the artery, thus significantly lowering the risk of blockages. For instance, in May 2024, Abbott introduced the XIENCE Sierra Everolimus eluting coronary stent system in India offering enhanced stent design with a new delivery system and unique sizes to aid in treating complex cases. The stent features a specialized coating to reduce artery re-blocking and has demonstrated efficacy in challenging lesions and complex conditions. In line with this, clinical studies have shown that DES improves long-term outcomes by reducing the need for repeat procedures compared to BMS. According to coronary stents market analysis, the market is set for significant growth due to the rising adoption of drug-eluting stents (DES) over bare-metal stents mainly driven by their superior performance in reducing restenosis and long-term complications.

Technological Advancements

Technological advancements in coronary stents include the development of bioresorbable stents which dissolve after their job is done, thus eliminating the need for long-term implants and reducing risks like late stent thrombosis. For instance, in July 2024, MicroPort Scientific Corporation's Firesorb(R) bioresorbable cardiac stent gained approval from the National Medical Products Administration in China. The stent has shown exceptional performance in clinical studies, with low rates of target lesion failure and thrombosis. Drug-coated balloons are another innovation that deliver drugs directly to the artery without leaving behind a permanent device generally ideal for complex lesions or patients with higher risks of restenosis. These technologies aim to improve patient outcomes by reducing long-term complications, enhancing vessel healing, and offering more personalized treatment options in coronary interventions.

Growing Geriatric Population and Rise of Cardiovascular Diseases

With the rising global geriatric population, the prevalence of cardiovascular diseases, particularly coronary artery disease, is on the rise. According to the report published by World Health Organization (WHO), by 2030, 1 in 6 people will be over 60 years old, and there will be 1.4 billion older individuals. By 2050, this number will double to 2.1 billion, with 426 million aged 80 or older. As arteries harden and narrow due to age-related factors like cholesterol buildup, elderly individuals are increasingly requiring coronary interventions. The higher susceptibility to heart conditions among this group drives the demand for coronary stents to restore blood flow and prevent complications like heart attacks. Advancements in stent technology combined with the need for safe more effective treatments in older patients, are contributing significantly to the coronary stents market growth. This demand is further fuelled by extended life expectancy and improved access to healthcare globally.

Key Market Segmentation:

Breakup by Type:

  • Drug-eluting Stents
  • Bare-metal Coronary Stents
  • Bioabsorbable Stents

Breakup by Biomaterial:

  • Metallic Biomaterial
  • Polymeric Biomaterial
  • Natural Biomaterial

Breakup by Mode of Delivery:

  • Balloon-expandable Stents
  • Self-expanding Stents

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global coronary stents market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Translumina GmbH

Key Questions Answered in This Report

  • 1.What was the size of the global coronary stents market in 2024?
  • 2.What is the expected growth rate of the global coronary stents market during 2025-2033?
  • 3.What are the key factors driving the global coronary stents market?
  • 4.What has been the impact of COVID-19 on the global coronary stents market?
  • 5.What is the breakup of the global coronary stents market based on the type?
  • 6.What is the breakup of the global coronary stents market based on biomaterial?
  • 7.What is the breakup of the global coronary stents market based on the mode of delivery?
  • 8.What is the breakup of the global coronary stents market based on the end user?
  • 9.What are the key regions in the global coronary stents market?
  • 10.Who are the key players/companies in the global coronary stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Coronary Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Drug-eluting Stents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bare-metal Coronary Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bioabsorbable Stents
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Biomaterial

  • 7.1 Metallic Biomaterial
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymeric Biomaterial
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Natural Biomaterial
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Mode of Delivery

  • 8.1 Balloon-expandable Stents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Self-expanding Stents
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Biotronik SE & Co. KG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 Boston Scientific Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Elixir Medical Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Lepu Medical Technology (Beijing) Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meril Life Sciences Pvt. Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 MicroPort Scientific Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Terumo Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Translumina GmbH
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Coronary Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Coronary Stents Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Coronary Stents Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Coronary Stents Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Coronary Stents Market: Breakup by Biomaterial (in %), 2024
  • Figure 6: Global: Coronary Stents Market: Breakup by Mode of Delivery (in %), 2024
  • Figure 7: Global: Coronary Stents Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Coronary Stents Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Coronary Stents (Drug-eluting Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Coronary Stents (Drug-eluting Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Coronary Stents (Bare-metal Coronary Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Coronary Stents (Bare-metal Coronary Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Coronary Stents (Bioabsorbable Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Coronary Stents (Bioabsorbable Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Coronary Stents (Metallic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Coronary Stents (Metallic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Coronary Stents (Polymeric Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Coronary Stents (Polymeric Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Coronary Stents (Natural Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Coronary Stents (Natural Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Coronary Stents (Balloon-expandable Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Coronary Stents (Balloon-expandable Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Coronary Stents (Self-expanding Stents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Coronary Stents (Self-expanding Stents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Coronary Stents (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Coronary Stents (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Coronary Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Coronary Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Coronary Stents (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Coronary Stents (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Coronary Stents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Coronary Stents Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Coronary Stents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Coronary Stents Industry: SWOT Analysis
  • Figure 81: Global: Coronary Stents Industry: Value Chain Analysis
  • Figure 82: Global: Coronary Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Coronary Stents Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Coronary Stents Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Coronary Stents Market Forecast: Breakup by Biomaterial (in Million USD), 2025-2033
  • Table 4: Global: Coronary Stents Market Forecast: Breakup by Mode of Delivery (in Million USD), 2025-2033
  • Table 5: Global: Coronary Stents Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Coronary Stents Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Coronary Stents Market: Competitive Structure
  • Table 8: Global: Coronary Stents Market: Key Players